Sign in

CIK 0001868279

  • Non-accelerated filer
  • Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Parsey Merdad Director Grant or award · Non-Qualified Stock Option (right to buy) +13,562 13,562
2025-06-18 Parsey Merdad Director Grant or award · Non-Qualified Stock Option (right to buy) +15,502 15,502
2025-04-28 Parsey Merdad Director Grant or award · Stock Option (right to buy) +28,346 28,346

Page 1 of 1 · 3 trades